Abstract
Augmented vasoconstriction is a hallmark of hypertension and is mediated partly by hyper-stimulation of G protein couple receptors (GPCRs) and downstream signaling components. Although GPCR blockade is a key component of current anti-hypertensive strategies, whether hypertension is better managed by directly targeting G proteins has not been thoroughly investigated. Here, we tested whether inhibiting G q/11 proteins in vivo and ex vivo using natural cyclic depsipeptide, FR900359 (FR) from the ornamental plant, Ardisia crenata, and YM-254890 (YM) from Chromobacterium sp. QS3666, or it's synthetic analog, WU-07047 (WU), was sufficient to reverse hypertension in mice. All three inhibitors blocked G protein-dependent vasoconstriction, but to our surprise YM and WU and not FR inhibited K + -induced Ca 2+ transients and vasoconstriction of intact vessels. However, each inhibitor blocked whole-cell L-type Ca 2+ channel current in vascular smooth muscle cells. Subcutaneous injection of FR or YM (0.3 mg/kg, s.c.) in normotensive and hypertensive mice elicited bradycardia and marked blood pressure decrease, which was more severe and long lasting after the injection of FR relative to YM (FR t1/2 ≅ 12 h vs. YM t1/2 ≅ 4 h). In deoxycorticosterone acetate (DOCA)-salt hypertension mice, chronic injection of FR (0.3 mg/kg, s.c., daily for seven days) reversed hypertension (vehicle SBP: 149 ± 5 vs. FR SBP: 117 ± 7 mmHg), without any effect on heart rate. Our results together support the hypothesis that increased LTCC and G q/11 activity is involved in the pathogenesis of hypertension, and that dual targeting of both proteins can reverse hypertension and associated cardiovascular disorders.
| Original language | English |
|---|---|
| Pages (from-to) | 264-275 |
| Number of pages | 12 |
| Journal | Pharmacological Research |
| Volume | 141 |
| DOIs | |
| State | Published - Mar 2019 |
Keywords
- Arginine vasopressin (CID: 644077)
- Bay K8644 (CID: 2303
- Blood pressure
- Calcium signaling
- Cyclic depsipeptides
- Endothelin-1 (CID: 16212950)
- FR900359 (CID: 14101198)
- G inhibitor ligands
- G proteins
- L-type calcium channel
- Nifedipine (CID: 63011)
- Phenylephrine (CID: 5284443)
- U46619 (CID: 5311493)
- WU-07047 (PMID: 25875152)
- YM-254890 (CID: 9919454)
Fingerprint
Dive into the research topics of 'Anti-hypertensive mechanisms of cyclic depsipeptide inhibitor ligands for G q/11 class G proteins'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver